Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia

NCT01923116 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Anal Intraepithelial Neoplasia
HIV

Interventions

DRUG: HPV-16 vaccine

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

[object Object]
[object Object]